Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism γ-secretase modulators(Gamma-secretase modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H22ClN5O2 |
InChIKeyIOQORVDNYPOZPL-MYKRFBFLSA-N |
CAS Registry2085780-87-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Lymphoproliferative Syndrome | Preclinical | US | 26 Nov 2021 |